Summary of the period

Second quarter: April 1st – June 30th, 2022

Numbers in parentheses refers to outcomes during the corresponding period of the previous year. 

  • Net revenue amounted to 470.9 MSEK (160.2 MSEK), corresponding to an increase of 194% 
  • Operational EBITDA amounted to 118.6 MSEK (48.2 MSEK), corresponding to an increase of 146%, and an EBITDA-margin of 25.2% (30.1%). The adjustments refer to an accounting adjustment of acquired inventory of 13.1 MSEK 
  • Organic, currency-adjusted growth amounted to 4% 
  • Operational EBIT amounted to 107.3 MSEK (45.0 MSEK), corresponding to an increase of 138% and an EBIT-margin of 22.8% (28.1%) 
  • Profit after tax amounted to 77.6 MSEK (15.2 MSEK) 
  • Earnings per share calculated on 158 111 805 shares 0.49 SEK (0.14 SEK)* 
  • As of June 30, 2022 cash amounted to 235.5 MSEK (1 261.0 MSEK) 

First 6 months, January 1st – June 30th, 2022

  • Net revenue amounted to 848.6 MSEK (294.1 MSEK), corresponding to an increase of 188% 
  • Operational EBITDA amounted to 213.3 MSEK (84.9 MSEK), corresponding to an increase of 151% and an EBITDA-margin of 25.1% (28.8%). The adjustments refer to costs in connection with the acquisition of NaturVet and Innovet of 11.2 MSEK and an accounting adjustment of acquired inventory of 17.5 MSEK 
  • Organic, currency-adjusted growth amounted to 6% 
  • Operational EBIT amounted to 189.1 MSEK (81.1 MSEK), corresponding to an increase of 133% and an EBIT-margin of 22.2% (27.6%) 
  • Profit after tax amounted to 103.0 MSEK (24.2 MSEK) 
  • Earnings per share calculated on 152 325 798 shares 0.68 SEK (0.23 SEK)* 
  • Cash flow from operating activities amounted to 65.9 MSEK (56.7 MSEK) 
  • Foreign exchange gains amounted to 4.4 MSEK 

* Converted to the number of shares after the share split 5:1 that took place in May 2021 

Significant events during the second quarter 

  • Swedencare´s subsidiary Vetio receives Intention to Grant from the European Patent Office (EPO) and Notice of Allowance from the United States Patent Office (USPTO) for its Starch-Free Soft Chew. 

Significant events after the second quarter 

  • Swedencare executes the earn-out payment of 27.5 MUSD in relation to the acquisition of NaturVet as the target for it was reached already in May. 
  • Investor contact

    If you have any questions or concerns- please do not hesitate to contact us!